Phosphodiesterase inhibitors stimulate osteoclast formation via TRANCE/RANKL expression in osteoblasts: possible involvement of ERK and p38 MAPK pathways
Masamichi Takami(Showa University), Mijung Yim(Sookmyung Women's University)
Cited by 68
Related Papers
PDE4 inhibitor upregulates PTH‐induced osteoclast formation via CRE‐mediated <i>COX‐2</i> expression in osteoblasts
|FEBS Letters|2009|13
Cetylpyridinium Chloride Inhibits Receptor Activator of Nuclear Factor-κB Ligand-Induced Osteoclast Formation
|Biological and Pharmaceutical Bulletin|2013|11
Rolipram, a Phosphodiesterase 4 Inhibitor, Stimulates Inducible cAMP Early Repressor Expression in Osteoblasts
|Yonsei Medical Journal|2005|11
3'4'7-Trihydroxyflavone inhibits RANKL-induced osteoclast formation via NFATc1
|Die Pharmazie|2015|4
Iris Koreana NAKAI Inhibits Osteoclast Formation via p38-Mediated Nuclear Factor of Activated T Cells 1 Signaling Pathway
|Journal of Bone Metabolism|2023|3